Michael L. Krall

MICHAEL L. KRALL is the President, CEO and Chairman of PURE Bioscience, a
position he has held since 1993. Originally founded as a pharmaceutical device
company, PURE has a long history of operating in the highly regulated
pharmaceutical industry. The original device division was sold in 2005 after
which PURE turned its complete attention and resources to developing and
commercializing its new molecular entity, silver dihydrogen citrate, as a broad
spectrum antimicrobial platform. With more than 30 years experience as an
entrepreneur and businessman, Mr. Krall’s prior leadership roles also include
ownership and executive management of a successful residential and commercial
building and development company.